US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Vertex Pharmaceuticals (NQ:VRTX)

517.49 -6.44 (-1.23%)
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
78 79 Next >
News headline image
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades. ↗
Via The Motley Fool
News headline image
Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗
 
Via Benzinga
News headline image
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? ↗
Via The Motley Fool
News headline image
Got $500? 1 Biotech Stock to Buy and Hold Forever ↗
Via The Motley Fool
News headline image
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics ↗
 
Via Benzinga
News headline image
3 Growth Stocks You Can Buy Right Now Without Any Hesitation ↗
Via The Motley Fool
News headline image
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity ↗
 
Via Benzinga
News headline image
Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts ↗
 
Via Benzinga
News headline image
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More ↗
Via The Motley Fool
News headline image
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity ↗
Regulators are reviewing what could become a multi-billion-dollar drug. 
Via The Motley Fool
News headline image
Biotech Stocks Are Rallying: What Is Your Playbook? ↗
If you have been reading our posts you know that some of the big biotech winners have taken a hit after earnings : LLY, MRK and REGN. But ABBV, GILD, LLY, and VRTX remain among the top performers. 
Via Talk Markets
News headline image
Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points ↗
Meta just forged a new base. All five stocks are on the IBD Leaderboard list. 
Via Investor's Business Daily
Topics Stocks
News headline image
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review ↗
A Fed rate cut and a slew of big earnings reports filled out a busy week. 
Via Investor's Business Daily
Topics Economy Government
News headline image
2 Biotech Stocks You Can Buy Hand Over Fist This Month ↗
Both stocks have made significant breakthroughs. 
Via The Motley Fool
News headline image
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday? ↗
Wall Street rallied on Tuesday as improved investor sentiment aligned with millions of Americans casting their votes for the 47th president. 
Via Benzinga
News headline image
5 Top Stocks to Buy in November ↗
From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know where to look. 
Via The Motley Fool
News headline image
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November ↗
The sky's the limit for these stocks. 
Via The Motley Fool
News headline image
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript ↗
VRTX earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms ↗
Vertex Pharmaceuticals beat third-quarter expectations on Monday. The company also raised its sales outlook. 
Via Investor's Business Daily
News headline image
Vertex Reports Third Quarter 2024 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required ↗
A bit of earnings and election jitters roiled the market last week reordering the leaderboard in biopharma stocks. 
Via Talk Markets
News headline image
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday? ↗
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
News headline image
Jim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts? ↗
VRTX to report Q3 earnings, expected EPS $4.14 and $2.72B in revenue. Cramer calls it a buy, analysts see 22% upside. Stock faces bearish trend. 
Via Benzinga
News headline image
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers ↗
It won't be able to be profitable without hitting its targets for both of these figures. 
Via The Motley Fool
News headline image
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report ↗
Amid the election, and a Fed rate vote, earnings season roars ahead. 
Via Investor's Business Daily
Topics Economy Stocks
News headline image
Jim Cramer: This Financial Stock Is 'One Of The Most Consistent, Great Companies' ↗
Mad Money's Jim Cramer recommends buying T. Rowe Price Group. "I think it's such a great company," he added. 
Via Benzinga
News headline image
Vertex to Participate in Upcoming November Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
These 10 Stocks Were The Best S&P 500 Performers In 2017 When Trump Was President: Will History Repeat Itself? ↗
A look back at the top 10 S&P 500 performing stocks in 2017 under Donald Trump's first year as president and what it could mean for his re-election efforts. 
Via Benzinga
Topics Government Stocks
News headline image
12 High-Growth Stocks That Could Deliver Parabolic Returns ↗
These 12 innovative companies could deliver exponential returns over the next quarter century. 
Via The Motley Fool
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
78 79 Next >